Why did Regeneron buy 23andMe for $256M?
How will US credit downgrade impact markets?
Why is Walmart raising prices due to tariffs?
What led JPMorgan to warn about stagflation?
How did China respond to US Huawei chip restrictions?
Why is Nvidia partnering to scale AI infrastructure?
What does the UK-EU post-Brexit reset entail?
How will Trump’s tax bill affect the economy?
Why is Blink Charging cutting workforce by 20%?
These Analysts Boost Their Forecasts On Acadia Pharmaceuticals
benzinga.com/25/05/45491578/these-analysts-boost-their-forecasts-on-acadia-pharmaceuticals
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) announced a favorable court ruling on Friday.
The U.S. District Court for the District of Delaware upheld the validity and found infringement of Acadia’s ‘721 formulation patent for NUPLAZID (pimavanserin), a treatment for Parkinson's Disease…
This story appeared on benzinga.com, 2025-05-19 12:25:20.